Foveal crowding appears to be robust to normal aging and glaucoma unlike parafoveal and peripheral crowding.


Journal

Journal of vision
ISSN: 1534-7362
Titre abrégé: J Vis
Pays: United States
ID NLM: 101147197

Informations de publication

Date de publication:
11 07 2022
Historique:
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 22 7 2022
Statut: ppublish

Résumé

Visual crowding is the inability to recognize a target object in clutter. Previous studies have shown an increase in crowding in both parafoveal and peripheral vision in normal aging and glaucoma. Here, we ask whether there is any increase in foveal crowding in both normal aging and glaucomatous vision. Twenty-four patients with glaucoma and 24 age-matched normally sighted controls (mean age = 65 ± 7 vs. 60 ± 8 years old) participated in this study. For each subject, we measured the extent of foveal crowding using Pelli's foveal crowding paradigm (2016). We found that the average crowding zone was 0.061 degrees for glaucoma and 0.056 degrees for age-matched normal vision, respectively. These values fall into the range of foveal crowding zones (0.0125 degrees to 0.1 degrees) observed in young normal vision. We, however, did not find any evidence supporting increased foveal crowding in glaucoma (p = 0.375), at least in the early to moderate stages of glaucoma. In the light of previous studies on foveal crowding in normal young vision, we did not find any evidence supporting age-related changes in foveal crowding. Even if there is any, the effect appears to be rather inconsequential. Taken together, our findings suggest unlike parafoveal or peripheral crowding (2 degrees, 4 degrees, 8 degrees, and 10 degrees eccentricities), foveal crowding (<0.25 degrees eccentricity) appears to be less vulnerable to normal aging or moderate glaucomatous damage.

Identifiants

pubmed: 35848904
pii: 2783491
doi: 10.1167/jov.22.8.10
pmc: PMC9308014
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Subventions

Organisme : NEI NIH HHS
ID : R01 EY027857
Pays : United States

Références

Vision Res. 2007 Jun;47(14):1950-62
pubmed: 17502115
Arch Ophthalmol. 2009 Jul;127(7):875-81
pubmed: 19597108
J Ophthalmol. 2016;2016:7074016
pubmed: 27872754
J Vis. 2004 Dec 30;4(12):1136-69
pubmed: 15669917
Sci Rep. 2018 Jun 15;8(1):9177
pubmed: 29907791
Curr Opin Neurobiol. 2008 Aug;18(4):445-51
pubmed: 18835355
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
J Opt Soc Am. 1963 Sep;53:1026-32
pubmed: 14065335
Trends Cogn Sci. 2011 Apr;15(4):160-8
pubmed: 21420894
Arch Ophthalmol. 1984 Mar;102(3):363-70
pubmed: 6703983
Arch Ophthalmol. 2011 Jan;129(1):16-22
pubmed: 21220624
Nature. 1970 Apr 11;226(5241):177-8
pubmed: 5437004
Curr Biol. 2015 Dec 21;25(24):3213-9
pubmed: 26628010
BMC Neurosci. 2006 Oct 03;7:66
pubmed: 17018142
Optom Vis Sci. 2006 Jul;83(7):444-54
pubmed: 16840870
JAMA Ophthalmol. 2020 Feb 1;138(2):190-198
pubmed: 31895454
Transl Vis Sci Technol. 2021 Dec 1;10(14):14
pubmed: 34910102
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3827-3836
pubmed: 30737290
J Vis. 2015;15(13):10
pubmed: 26381841
Prog Retin Eye Res. 2017 Mar;57:46-75
pubmed: 28012881
Sci Rep. 2017 Aug 15;7(1):8271
pubmed: 28811585
Percept Psychophys. 1984 Nov;36(5):457-60
pubmed: 6533567
Ophthalmology. 2013 Apr;120(4):736-44
pubmed: 23246120
Ophthalmology. 2008 Jun;115(6):941-948.e1
pubmed: 17997485
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):E3573-E3582
pubmed: 28396415
Br J Ophthalmol. 2016 Nov;100(11):1585-1590
pubmed: 27503395
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):36
pubmed: 35084432
Nat Neurosci. 2008 Oct;11(10):1129-35
pubmed: 18828191
J R Soc Interface. 2015 Feb 6;12(103):
pubmed: 25505132
J Glaucoma. 2003 Apr;12(2):134-8
pubmed: 12671468
J Glaucoma. 2021 Feb 1;30(2):140-147
pubmed: 33074958
Arch Ophthalmol. 2009 Jan;127(1):82-7
pubmed: 19139345
Transl Vis Sci Technol. 2012 May 25;1(1):3
pubmed: 23626924
Ophthalmology. 2013 Jun;120(6):1120-6
pubmed: 23415421
Prog Retin Eye Res. 2013 Jan;32:1-21
pubmed: 22995953
Curr Biol. 2011 Feb 8;21(3):254-8
pubmed: 21277208
Optom Vis Sci. 2021 Jan 1;98(1):41-50
pubmed: 33394930
Percept Psychophys. 1991 Jun;49(6):495-508
pubmed: 1857623
Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):305-14
pubmed: 17934750
Transl Vis Sci Technol. 2015 Nov 30;4(6):4
pubmed: 26644964
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5810-5818
pubmed: 29131903
J Ophthalmol. 2014;2014:120528
pubmed: 24883203
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2304-20
pubmed: 9804139
Invest Ophthalmol Vis Sci. 2014 Feb 03;55(2):632-49
pubmed: 24370831
J Glaucoma. 2020 Jan;29(1):71-75
pubmed: 31567752
Percept Psychophys. 1983 Feb;33(2):113-20
pubmed: 6844102
Vision Res. 1992 Jul;32(7):1349-57
pubmed: 1455707
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3629-37
pubmed: 22511628
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):27
pubmed: 35179554
Sci Rep. 2014 Feb 12;4:4067
pubmed: 24518803
PLoS One. 2018 Feb 26;13(2):e0193465
pubmed: 29481572
Spat Vis. 1997;10(4):437-42
pubmed: 9176953
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4437-43
pubmed: 18539947
Ger J Ophthalmol. 1995 Mar;4(2):97-102
pubmed: 7795517
Vision Res. 2005 Mar;45(5):617-33
pubmed: 15621179
Arch Ophthalmol. 2009 Sep;127(9):1136-45
pubmed: 19752422
Trans Am Ophthalmol Soc. 2001;99:213-7; discussion 217-8
pubmed: 11797309
Nat Neurosci. 2001 Jul;4(7):739-44
pubmed: 11426231
Br J Ophthalmol. 2000 Mar;84(3):303-10
pubmed: 10684843
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Br J Ophthalmol. 1999 May;83(5):546-52
pubmed: 10216052
Vision Res. 2013 Jan 25;77:10-3
pubmed: 23200866
J Neurosci. 2008 Mar 12;28(11):2735-44
pubmed: 18337403
Invest Ophthalmol Vis Sci. 2015 Mar 03;56(3):1537-45
pubmed: 25737150
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):538-543
pubmed: 30716149
J Vis. 2009 Nov 19;9(12):13.1-18
pubmed: 20053104
J Vis. 2007 Oct 26;7(2):21.1-17
pubmed: 18217836
J Vis. 2007 Mar 07;7(2):9.1-15
pubmed: 18217824
JAMA Ophthalmol. 2013 Dec;131(12):1554-62
pubmed: 24263699
Vision Res. 2013 May 24;84:50-9
pubmed: 23563172
PLoS One. 2013 Aug 19;8(8):e72282
pubmed: 23977271
Am J Ophthalmol. 2019 Dec;208:415-420
pubmed: 31493403
Nature. 1996 Sep 26;383(6598):334-7
pubmed: 8848045
Optom Vis Sci. 2012 Sep;89(9):1282-7
pubmed: 22885786
J Vis. 2002;2(2):140-66
pubmed: 12678589
Ann Neurol. 1993 Mar;33(3):248-57
pubmed: 8498808
Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):666-72
pubmed: 23074207
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6221-6231
pubmed: 29228250
J Vis. 2007 Nov 27;7(2):25.1-18
pubmed: 18217840
J Vis. 2022 Feb 1;22(2):15
pubmed: 35195672

Auteurs

Foroogh Shamsi (F)

Department of Psychology, Northeastern University, Boston, MA, USA.
f.shamsi@northeastern.edu.

Rong Liu (R)

Department of Psychology, Northeastern University, Boston, MA, USA.
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Life Science and Medicine, University of Science and Technology of China, Hefei, China.
rongliu@ustc.edu.cn.

MiYoung Kwon (M)

Department of Psychology, Northeastern University, Boston, MA, USA.
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
m.kwon@northeastern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH